| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68,399 |
56,433 |
$4.40M |
| 99199 |
Unlisted special service, procedure or report |
653,399 |
327,899 |
$3.91M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
26,879 |
22,425 |
$2.32M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
24,589 |
20,856 |
$2.24M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,770 |
15,683 |
$1.66M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
67,309 |
56,347 |
$1.28M |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
35,799 |
30,117 |
$1.19M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,427 |
9,635 |
$1.12M |
| D0145 |
Oral evaluation for a patient under three years of age |
19,517 |
16,732 |
$632K |
| 99215 |
Prolong outpt/office vis |
2,549 |
2,210 |
$310K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,792 |
2,141 |
$282K |
| D1206 |
Topical application of fluoride varnish |
19,527 |
16,794 |
$280K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,749 |
6,667 |
$270K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
27,789 |
23,365 |
$259K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
2,670 |
1,721 |
$189K |
| 90474 |
|
9,183 |
7,978 |
$175K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,724 |
2,251 |
$121K |
| 96127 |
|
26,901 |
22,547 |
$115K |
| 99245 |
|
468 |
436 |
$86K |
| 99051 |
|
3,089 |
2,601 |
$75K |
| 87428 |
|
899 |
819 |
$55K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,517 |
1,057 |
$55K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,693 |
1,596 |
$51K |
| 83655 |
|
3,401 |
2,825 |
$45K |
| 96161 |
|
12,753 |
10,574 |
$44K |
| 99381 |
|
417 |
306 |
$27K |
| 0072A |
|
341 |
250 |
$22K |
| 92551 |
|
24,701 |
20,336 |
$16K |
| 0001A |
|
274 |
233 |
$15K |
| 90834 |
Psychotherapy, 45 minutes with patient |
241 |
218 |
$14K |
| 90837 |
Psychotherapy, 53 minutes with patient |
165 |
139 |
$14K |
| 99173 |
|
31,859 |
26,483 |
$14K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
460 |
458 |
$13K |
| 85018 |
|
7,610 |
6,295 |
$12K |
| 0071A |
|
173 |
136 |
$11K |
| 90686 |
|
27,388 |
22,798 |
$11K |
| 92587 |
|
2,117 |
1,906 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
657 |
503 |
$8K |
| 99442 |
|
129 |
127 |
$7K |
| 99401 |
|
346 |
175 |
$6K |
| 96160 |
|
1,597 |
1,179 |
$5K |
| 0002A |
|
75 |
69 |
$5K |
| 90651 |
|
462 |
360 |
$5K |
| 81025 |
|
676 |
550 |
$4K |
| 99441 |
|
130 |
125 |
$4K |
| 88720 |
|
668 |
474 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
23 |
17 |
$3K |
| 99443 |
|
43 |
40 |
$3K |
| 99383 |
|
25 |
25 |
$2K |
| 90734 |
|
243 |
187 |
$2K |
| 90656 |
|
1,318 |
1,262 |
$1K |
| 0052A |
|
26 |
14 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
40 |
25 |
$1K |
| 87807 |
|
74 |
58 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
395 |
358 |
$947.70 |
| 96131 |
|
19 |
12 |
$722.61 |
| 86703 |
|
125 |
81 |
$665.15 |
| 90716 |
|
530 |
441 |
$543.02 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
26 |
$453.68 |
| 90633 |
|
4,399 |
3,728 |
$410.97 |
| 98968 |
|
16 |
12 |
$401.50 |
| 90744 |
|
5,681 |
4,744 |
$373.18 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
14 |
$325.47 |
| 90707 |
|
482 |
403 |
$311.73 |
| 90677 |
|
855 |
846 |
$265.10 |
| 91300 |
|
328 |
277 |
$236.36 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17 |
13 |
$132.34 |
| 91307 |
|
890 |
697 |
$60.64 |
| 90715 |
|
35 |
25 |
$44.68 |
| 90698 |
|
11,593 |
9,888 |
$10.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
12 |
$10.61 |
| 91308 |
|
31 |
24 |
$0.45 |
| 90680 |
|
9,322 |
8,058 |
$0.34 |
| 90670 |
|
17,360 |
14,604 |
$0.24 |
| 90671 |
|
40 |
32 |
$0.05 |
| 90619 |
|
72 |
65 |
$0.01 |
| 3078F |
|
750 |
738 |
$0.00 |
| 90710 |
|
226 |
190 |
$0.00 |
| 90648 |
|
152 |
137 |
$0.00 |
| 90685 |
|
669 |
607 |
$0.00 |
| 90700 |
|
222 |
193 |
$0.00 |
| 3074F |
|
776 |
760 |
$0.00 |
| 90697 |
|
133 |
132 |
$0.00 |
| 90696 |
|
224 |
173 |
$0.00 |
| 3044F |
|
14 |
14 |
$0.00 |
| 91305 |
|
78 |
46 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
18 |
12 |
$0.00 |